| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 23.07B | 21.66B | 22.04B | 17.54B | 25.29B | 20.50B |
| Gross Profit | 7.77B | 7.08B | 7.11B | 5.06B | 8.18B | 6.39B |
| EBITDA | 3.14B | 2.17B | 2.89B | 1.09B | 3.62B | 2.68B |
| Net Income | 952.02M | 323.53M | 964.91M | -72.80M | 2.29B | 1.57B |
Balance Sheet | ||||||
| Total Assets | 43.86B | 44.96B | 46.39B | 42.95B | 39.51B | 35.43B |
| Cash, Cash Equivalents and Short-Term Investments | 9.49B | 10.52B | 9.46B | 9.03B | 9.53B | 9.77B |
| Total Debt | 5.86B | 6.21B | 6.74B | 8.01B | 5.28B | 5.22B |
| Total Liabilities | 11.76B | 11.15B | 12.75B | 12.35B | 10.31B | 10.06B |
| Stockholders Equity | 31.01B | 32.62B | 32.48B | 29.61B | 28.30B | 24.60B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.15B | 1.40B | -1.85B | 232.93M | 1.12B |
| Operating Cash Flow | 0.00 | 2.63B | 2.44B | 765.57M | 1.86B | 1.88B |
| Investing Cash Flow | 0.00 | -310.56M | -1.64B | -3.30B | -1.88B | -432.10M |
| Financing Cash Flow | 0.00 | -2.00B | -1.52B | 1.30B | -1.18B | -673.55M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥25.66B | 46.66 | ― | 2.77% | -7.31% | -44.40% | |
64 Neutral | ¥17.25B | 8.12 | ― | 1.73% | 14.34% | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
59 Neutral | ¥31.03B | 4.17 | ― | 2.13% | 1.00% | 24.79% | |
55 Neutral | ¥19.20B | 56.74 | ― | 2.38% | -1.74% | -66.01% | |
53 Neutral | ¥11.94B | -5.58 | ― | ― | 6.21% | -122.67% | |
50 Neutral | ¥18.57B | 124.61 | ― | ― | -8.87% | ― |